In this study, we aimed to compare serum PGRN(progranulin) and TNF-α levels in AS patients with healthy controls and to determine the relationship between TNF-α inhibitor use and PGRN levels in AS patients.
Eligibility
Sex
ALL
Min age
20 Years
Max age
65 Years
Healthy volunteers
Accepted
Inclusion Criteria:
* Between the ages of 20-65
* Signing the informed consent form
* Axial spondyloarthropathy diagnosis according to ASAS 2009 criteria
Exclusion Criteria:
* Pregnancy or lactation
* Having signs of acute or chronic infection
* Presence of malignancy
* Having concurrent secondary rheumatic disease other than Axial Spondyloarthropathy
Primary outcome measure(s)
In this study, we aimed to compare serum PGRN and TNF-α levels in AS patients with healthy controls and to determine the relationship between TNF-α inhibitor use and PGRN levels in AS patients. — Patient will be seen only once In this study, we aimed to compare serum PGRN and TNF-α levels in AS patients with healthy controls and to determine the relationship between TNF-α inhibitor use and PGRN levels in AS patients.
Trial sites (1)
Facility
City
Region
Status
Kırşehir Ahi Evran University
Kırşehir
Turkey (Türkiye)
More Kirsehir Ahi Evran Universitesi trials in Turkey
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.
